Highlights of Our NGS Program
A complete spectrum of testing options - The most comprehensive combination of tests spanning from single-gene, disease-specific and broad reach tumor profiles in tissue and plasma specimens, in addition to bone marrow and peripheral blood samples.
Full-range molecular diagnostic technologies – NGS is a molecular methodology that is part of a broader family of molecular tests. In addition to NGS, NeoGenomics provides a wide array of quantitative PCR, Sanger sequencing, and send-out SNP microarray services.
Heme Targeted Profiles - Actionable disease - specific profiles, such as NeoTYPE® MDS/CMML Profile that informs diagnosis, prognosis and predictive information.
RNA-Based Fusion Panels for Solid Tumors - Pan-tumor and disease-specific panels to guide therapeutic management, such as NTRK NGS Fusion Panel to detect NTRK1/2/3 for TRK inhibitor therapy eligibility.
Learn about NGS testing at NeoGenomics
NeoGenomics prides itself on our unparalleled customer support team. If you have questions regarding test information, specimen requirements, turnaround times, test add-on, and patient results please feel free to reach out to a Client Services Advocate at email@example.com.
View our full menu of available NGS tests with printable descriptions and specimen requirements.
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients